Bharat Biotech arm partners with VeGen Bio to develop India’s first dual-target car-T cell therapy The Times of India 2d
Bharat Biotech’s Crdmo Nucelion Partners VeGen Bio to develop India’s first dual-target car-T cell therapy The Times of India 2d
Before ‘You Can See Everything,’ there was another Elizabeth Holmes documentary: ‘The Inventor’ Los Angeles Times 2d All sources
China proposes export controls for solar tech amid safety concerns Silicon Republic 4d Biotech Pharma IT All sources
US to restrict investments in Chinese biotech firms Hong Kong Standard 10h Biotech Pharma All sources
Dodo could be brought back from extinction as AI 'finds 2,300 genetic features' Daily Star 7d Extinction Biotech Pharma Article paywall All sources
Gilead spends $1.28bn on PepStar’s potential Icotyde rival Pharmaceutical Technology 2h Gilead Sciences Biotech
Bottom of the Hill sold to biotech executive, will stay open as S.F. music venue San Francisco Chronicle 13h Biotech Biotechnology
Amgen vs. Eli Lilly: Does the GLP-1 mania make LLY stock a better buy in 2026? The Motley Fool 16h Eli Lilly Amgen Biotechnology
